(Q34196648)

31 July 2017

1 reference

title

Zafirlukast: an update of its pharmacology and therapeutic efficacy in asthma (English)

1 reference

31 July 2017

1 reference

1 reference

1 reference

C J Dunn

1

1 reference

31 July 2017

K L Goa

series ordinal

2

1 reference

31 July 2017

language of work or name

1 reference

1 January 2001

1 reference

31 July 2017

1 reference

31 July 2017

volume

61

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

285-315

1 reference

Leukocytes and mediators in bronchoalveolar lavage during allergen-induced late-phase asthmatic reactions

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200161020-00012

Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200161020-00012

Severe liver injury after treatment with the leukotriene receptor antagonist zafirlukast

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200161020-00012

Effect of long-term treatment with salmeterol on asthma control: a double blind, randomised crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200161020-00012

Preclinical exploration of the potential antiinflammatory properties of the peptide leukotriene antagonist ICI 204,219 (Accolate).

21 January 2018

1 reference

12 December 2020

Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor

1 reference

12 December 2020

Therapeutic effect of zafirlukast as monotherapy in steroid-naive patients with severe persistent asthma

1 reference

12 December 2020

Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction.

1 reference

12 December 2020

Lack of effect of zafirlukast on the pharmacokinetics of azithromycin, clarithromycin, and 14-hydroxyclarithromycin in healthy volunteers

1 reference

12 December 2020

Effects of 2 weeks of treatment with fluticasone propionate 100 mcg b.d. by comparison with zafirlukast 20 mg b.d. on bronchial hyper-responsiveness in patients with mild to moderate asthma

1 reference

12 December 2020

Improving outcomes in elderly patients with asthma

1 reference

12 December 2020

Increases in 5-lipoxygenase activating protein expression account for enhanced capacity for 5-lipoxygenase metabolism that accompanies differentiation of peripheral blood monocytes into alveolar macrophages

1 reference

12 December 2020

Effect of age on response to zafirlukast in patients with asthma in the Accolate Clinical Experience and Pharmacoepidemiology Trial (ACCEPT)

1 reference

12 December 2020

Efficacy and duration of action of the antileukotriene zafirlukast on cold air-induced bronchoconstriction

1 reference

12 December 2020

Mucosal inflammation in asthma

1 reference

12 December 2020

Comparison of patients' compliance with prescribed oral and inhaled asthma medications

1 reference

12 December 2020

Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group

1 reference

12 December 2020

Effect of the oral leukotriene antagonist, ICI 204,219, on antigen-induced bronchoconstriction in subjects with asthma

1 reference

12 December 2020

Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist

1 reference

12 December 2020

The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock

1 reference

12 December 2020

Effects of leukotriene D on the airways in asthma

1 reference

12 December 2020

Effectiveness and tolerability of zafirlukast for the treatment of asthma in children

1 reference

12 December 2020

Long-term safety and efficacy of zafirlukast in the treatment of asthma: interim results of an open-label extension trial

1 reference

12 December 2020

Difficult asthma or Churg-Strauss syndrome?

1 reference

12 December 2020

Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids

1 reference

12 December 2020

Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis

1 reference

12 December 2020

An evaluation of zafirlukast in the treatment of asthma with exploratory subset analyses

1 reference

12 December 2020

Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients

1 reference

12 December 2020

Prostanoid and leukotriene receptors: a progress report from the IUPHAR working parties on classification and nomenclature.

1 reference

12 December 2020

Effect of leukotriene receptor antagonist therapy on the risk of asthma exacerbations in patients with mild to moderate asthma: an integrated analysis of zafirlukast trials

1 reference

12 December 2020

Liberation of histamine and formation of lysocithin-like substances by cobra venom

1 reference

12 December 2020

Inhibition of platelet-activating factor-induced bronchoconstriction by the leukotriene D4 receptor antagonist ICI 204,219

1 reference

12 December 2020

The leukotriene D4-receptor antagonist zafirlukast attenuates exercise-induced bronchoconstriction in children

1 reference

12 December 2020

5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes

1 reference

12 December 2020

Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics

1 reference

12 December 2020

Leukotriene modifiers and Churg-Strauss syndrome: adverse effect or response to corticosteroid withdrawal?

1 reference

12 December 2020

Salmeterol compared with current therapies in chronic asthma

1 reference

12 December 2020

Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles. Demonstration of glutathione-dependent vincristine transport

1 reference

12 December 2020

Slow-reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in vitro

1 reference

12 December 2020

Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects

1 reference

12 December 2020

The leukotriene-antagonist ICI-204,219 inhibits the early airway reaction to cumulative bronchial challenge with allergen in atopic asthmatics

1 reference

12 December 2020

Zafirlukast and Churg-Strauss syndrome

1 reference

12 December 2020

Reference spirometric values using techniques and equipment that meet ATS recommendations

1 reference

12 December 2020

The preclinical pharmacology of ICI 204,219. A peptide leukotriene antagonist

1 reference

12 December 2020

Treatment preferences of adolescent patients with asthma

1 reference

12 December 2020

Churg-Strauss syndrome and antiasthma therapy

1 reference

12 December 2020

The identification of a distinct export step following the biosynthesis of leukotriene C4 by human eosinophils

1 reference

12 December 2020

Salmeterol. A review of its pharmacological properties and clinical efficacy in the management of children with asthma

1 reference

12 December 2020

Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects

1 reference

12 December 2020

Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol

1 reference

12 December 2020

Leukotriene receptor antagonists and biosynthesis inhibitors: potential breakthrough in asthma therapy.

1 reference

12 December 2020

Steroids and Churg-Strauss syndrome

1 reference

12 December 2020

Bronchoconstrictor effects of leukotriene C in humans

1 reference

12 December 2020

A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis

1 reference

12 December 2020

Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group

1 reference

12 December 2020

Churg-Strauss syndome

1 reference

12 December 2020

Antileukotrienes in chronic urticaria

1 reference

12 December 2020

Potent leukotriene D4 receptor antagonist ICI 204,219 given by the inhaled route inhibits the early but not the late phase of allergen-induced bronchoconstriction

1 reference

12 December 2020

Expression cloning of a cDNA for human leukotriene C4 synthase, an integral membrane protein conjugating reduced glutathione to leukotriene A4

1 reference

12 December 2020

Characterization of the human cysteinyl leukotriene 2 receptor

1 reference

12 December 2020

Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group

1 reference

12 December 2020

Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma

1 reference

12 December 2020

Churg-Strauss syndrome after zafirlukast in two patients not receiving systemic steroid treatment

1 reference

12 December 2020

Guidelines update: where do the new therapies fit in the management of asthma? NHLBI and WHO Global Initiative for Asthma

1 reference

12 December 2020

The mechanism of vascular leakage induced by leukotriene E4. Endothelial contraction

1 reference

12 December 2020

Leukotriene E4 and granulocytic infiltration into asthmatic airways

1 reference

12 December 2020

Diurnal change of bronchial caliber and airway responsiveness in asthmatics during long-term treatment with long-acting beta 2-agonist salmeterol

1 reference

12 December 2020

Compliance with an oral asthma medication: a pilot study using an electronic monitoring device

1 reference

12 December 2020

Zafirlukast. A review of its pharmacology and therapeutic potential in the management of asthma

1 reference

12 December 2020

Role of phospholipase in generating lipid second messengers in signal transduction

1 reference

12 December 2020

Inhibition of leukotriene D4-induced bronchoconstriction in subjects with asthma: a concentration-effect study of ICI 204,219.

1 reference

12 December 2020

Asthma control during long-term treatment with regular inhaled salbutamol and salmeterol.

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled trial of the effect of zafirlukast on upper and lower respiratory responses to cat challenge

1 reference

12 December 2020

Inhibition of leukotriene D4-induced bronchoconstriction in normal subjects by the oral LTD4 receptor antagonist ICI 204,219.

1 reference

12 December 2020

Third International Pediatric Consensus statement on the management of childhood asthma. International Pediatric Asthma Consensus Group

1 reference

12 December 2020

Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol

1 reference

12 December 2020

The protective effect of inhaled leukotriene D4 receptor antagonist ICI 204,219 against exercise-induced asthma

1 reference

12 December 2020

Tolerability of leukotriene modifiers in asthma: a review of clinical experience

1 reference

12 December 2020

Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma

1 reference

12 December 2020

Recombinant mouse leukotriene A4 hydrolase: a zinc metalloenzyme with dual enzymatic activities.

1 reference

12 December 2020

Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis

1 reference

12 December 2020

Inhaled fluticasone propionate: a review of its therapeutic efficacy at dosages < or = 500 microg/day in adults and adolescents with mild to moderate asthma

1 reference

12 December 2020

A six-month, placebo-controlled comparison of the safety and efficacy of salmeterol or beclomethasone for persistent asthma

1 reference

12 December 2020

Salmeterol tachyphylaxis in steroid treated asthmatic subjects

1 reference

12 December 2020

Regulatory functions of phospholipase A2.

1 reference

12 December 2020

Leukotrienes are potent constrictors of human bronchi

1 reference

12 December 2020

Randomized placebo-controlled study comparing a leukotriene receptor antagonist and a nasal glucocorticoid in seasonal allergic rhinitis

1 reference

12 December 2020

10.2165/00003495-200161020-00012

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1015069044

0 references

1 reference